A smoking related triad: PAD, COPD and CCF

Australian Family Physician

Volumn 33, Issue 4, 2004, Pages 207-210

  Harris, Mark ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; GENERAL PRACTICE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NOTE; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PERIPHERAL VASCULAR DISEASE; SMOKING; SMOKING CESSATION;

BEHAVIOR THERAPY; FAMILY PRACTICE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PERIPHERAL VASCULAR DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SMOKING CESSATION;

EID: 3042845658     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jackson R. University of Auckland. Equation based on Anderson et al CVD risk profiles. Am Heart J 1991;121:293-298.
2. Davis RC, Hobbs FD, Lip GY. ABC of heart failure. History and epidemiology. BMJ 2000;320:39-42.
3. Madison JM, Irwin RS. Chronic obstructive pulmonary disease. Lancet 1998;352:467-473.
4. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999. Available at: www.aihw.gov.au.
5. Fletcher C, Peto R. The natural history of chronic airflow limitation. BMJ 1977;1:1645-1648.
6. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205.
7. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guidelines. Rockville, MD: US Department of Health and Human Services. Public Health Service, June 2000.
8. School of Public Health and Community Medicine UNSW, The Cancer Council of Victoria, General Practice Education Australia, and the Department of General Practice, Flinders University. Smoking cessation guidelines for Australian general practice: draft practice handbook. June 2003.,
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
10. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet 1999;353:2001-2007.
11. National Heart Foundation of Australia. Coronary heart disease: secondary prevention guidelines, 2003.
12. National Heart Foundation of Australia and Cardiac Societyof Australia and New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Panel. Guidelines on the contemporary management of the patient with chronic heart failure in Australia. Med J Aust 2001;174:459-466.
13. McKenzie DK, Frith PA, Burdon JGW, Town GI. The COPDX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease. Med J Aust 2003;178(6 Suppl):S1-S40.
14. The Australian Lung Foundation and The Thoracic Society of Australia and New Zealand. Chronic obstructive pulmonary disease. Australian and New Zealand management guidelines and the COPD handbook. Version 1. November, 2002.,
15. NHLBI/WHO Workshop Report. Global initiative for chronic obstructive lung disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. National Institutes of Health, National Heart, Lung and Blood Institute, April 2001.,
16. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 4, 2002.
17. Gravil JH, Al-Rawas OA, Cotton MM, Flanigan U, Irwin A, Stevenson RD. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet 1998;351:1853-1855.
18. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999;54:688-692.